133 related articles for article (PubMed ID: 38890744)
1. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
[TBL] [Abstract][Full Text] [Related]
2. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya.
Pintye J; Odoyo J; Nyerere B; Achieng P; Araka E; Omondi C; Ortblad KF; Mugambi ML; Baeten JM; Bukusi EA
AIDS; 2023 Mar; 37(4):617-623. PubMed ID: 36653342
[TBL] [Abstract][Full Text] [Related]
3.
Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
[TBL] [Abstract][Full Text] [Related]
4. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
5. Standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial.
Larsen A; Wilson KS; Kinuthia J; John-Stewart G; Richardson BA; Pintye J; Abuna F; Lagat H; Owens T; Kohler P
BMJ Open; 2020 Jun; 10(6):e035689. PubMed ID: 32565464
[TBL] [Abstract][Full Text] [Related]
6. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
[TBL] [Abstract][Full Text] [Related]
7. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
8. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
[TBL] [Abstract][Full Text] [Related]
9. Peer PrEP referral + HIV self-test delivery for PrEP initiation among young Kenyan women: study protocol for a hybrid cluster-randomized controlled trial.
Wairimu N; Malen RC; Reedy AM; Mogere P; Njeru I; Culquichicón C; McGowan M; Gao F; Baeten JM; Ngure K; Ortblad KF
Trials; 2023 Nov; 24(1):705. PubMed ID: 37925450
[TBL] [Abstract][Full Text] [Related]
10. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
[TBL] [Abstract][Full Text] [Related]
11. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial.
Velloza J; Poovan N; Ndlovu N; Khoza N; Morton JF; Omony J; Mkwanazi E; Grabow C; Donnell D; Munthali R; Baeten JM; Hosek S; Celum C; Delany-Moretlwe S
PLoS One; 2022; 17(4):e0266665. PubMed ID: 35417485
[TBL] [Abstract][Full Text] [Related]
12. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
[TBL] [Abstract][Full Text] [Related]
13. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
[TBL] [Abstract][Full Text] [Related]
14. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
[TBL] [Abstract][Full Text] [Related]
15. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
[TBL] [Abstract][Full Text] [Related]
16. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
[TBL] [Abstract][Full Text] [Related]
18. An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.
Donenberg GR; Atujuna M; Merrill KG; Emerson E; Ndwayana S; Blachman-Demner D; Bekker LG
BMC Public Health; 2021 Sep; 21(1):1708. PubMed ID: 34544403
[TBL] [Abstract][Full Text] [Related]
19. My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
Haberer JE; Oware K; Juma L; Nyerere B; Momanyi V; Odoyo J; Garrison L; Bhagat J; Musinguzi N; Baeten JM; Siegler A; Bukusi EA
J Int AIDS Soc; 2024 Feb; 27(2):e26217. PubMed ID: 38379132
[TBL] [Abstract][Full Text] [Related]
20. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
Roberts ST; Hartmann M; Minnis AM; Otticha SO; Browne EN; Montgomery ET; Agot K
J Int AIDS Soc; 2023 Dec; 26(12):e26198. PubMed ID: 38123866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]